Inhaltsverzeichnis
Auswahl der wissenschaftlichen Literatur zum Thema „Design de Molécules“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Design de Molécules" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Design de Molécules"
Tartour, Eric. „Vaccins anti-cancer : quel avenir dans les stratégies d’immunothérapie anti-cancéreuse ?“ Biologie Aujourd'hui 212, Nr. 3-4 (2018): 69–76. http://dx.doi.org/10.1051/jbio/2019002.
Der volle Inhalt der QuelleBoubekeur-Lecaque, Leïla, Nordin Felidj und Marc Lamy de la Chapelle. „Comprendre. La diffusion Raman exaltée de surface“. Photoniques, Nr. 90 (Januar 2018): 41–44. http://dx.doi.org/10.1051/photon/20189041.
Der volle Inhalt der QuelleLuiz, Isadora Lauris, Renato Massaharu Hassunuma, Patrícia Carvalho Garcia und Sandra Heloisa Nunes Messias. „APLICAÇÃO DIDÁTICA DE QUEBRA-CABEÇAS DO JOGO EteRNA PARA O ENSINO SOBRE A EDIÇÃO E DOBRAMENTO DE MOLÉCULAS DE RNA“. Revista Multidisciplinar de Educação e Meio Ambiente 4, Nr. 4 (13.12.2023): 1–18. http://dx.doi.org/10.51189/integrar/rema/4169.
Der volle Inhalt der QuelleUrdaneta, Johan, Humberto Soscún, Ana Ocando und Alberto Campos. „Propiedades ópticas no lineales del difosfaferroceno. Un estudio teórico“. Revista Bases de la Ciencia. e-ISSN 2588-0764 3, Nr. 3 (26.12.2018): 11. http://dx.doi.org/10.33936/rev_bas_de_la_ciencia.v3i3.1575.
Der volle Inhalt der QuelleLima, Aurineide Ribeiro, Emanuelle Machado Marinho, Jacilene Silva, Márcia Machado Marinho und Emmanuel Silva Marinho. „ESTUDO IN SILICO DO FLAVONOIDE ANTITROMBÓTICO TERNATIN, PRESENTE NOS CAPÍTULOS FLORAIS DE EGLETES VISCOSA LESS "MACELA-DA-TERRA"“. Revista Expressão Católica Saúde 2, Nr. 1 (30.04.2018): 23. http://dx.doi.org/10.25191/recs.v2i1.2095.
Der volle Inhalt der QuelleGuía Yanes, Marlin Angélica. „Técnicas para el análisis de poblaciones de la molécula de fibrinógeno“. Revista Criterio 3, Nr. 5 (01.10.2023): 21–27. http://dx.doi.org/10.62319/criterio.v.2i5.20.
Der volle Inhalt der QuelleSiedler, Marcelo da Silveira, Rafael Cunha Cardoso, Bernardo dos Santos Lacerda und Bruna de Souza Goldani. „MoleculAR“. Educitec - Revista de Estudos e Pesquisas sobre Ensino Tecnológico 8, : (10.10.2022): e200622. http://dx.doi.org/10.31417/educitec.v8.2006.
Der volle Inhalt der QuelleRodrigues, Sérgio Paulo Jorge, und Pedro Caridade. „História da química computacional e do uso dos computadores em química“. História da Ciência e Ensino: construindo interfaces 25 (29.09.2022): 140–53. http://dx.doi.org/10.23925/2178-2911.2022v25espp140-153.
Der volle Inhalt der QuelleBorcard, Rafael da Silva, João Victor Carvalho Magalhães und Maria das Graças Ferreira da Silva. „Mapeamento topológico do receptor TGFβ1 em modelos 2D“. CONTRIBUCIONES A LAS CIENCIAS SOCIALES 17, Nr. 5 (09.05.2024): e6747. http://dx.doi.org/10.55905/revconv.17n.5-098.
Der volle Inhalt der QuelleDávalos Merino, Guillermo Eduardo, Juan Carlos Medina Fonseca, Rosalia Dayrobi Arteaga Ledesma und José Indalindo Loor Loor. „Terapia regenerativa de glándulas mamarias en vacas con mastitis subclinica mediante el uso de plasma sanguíneo“. Conocimiento global 9, Nr. 2 (11.07.2024): 256–69. http://dx.doi.org/10.70165/cglobal.v9i2.419.
Der volle Inhalt der QuelleDissertationen zum Thema "Design de Molécules"
Côté, Simon. „Design, synthèse et caractérisation de molécules peptidiques fonctionnelles“. Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/MQ38055.pdf.
Der volle Inhalt der QuelleSperandio, Olivier. „Applications et développements informatiques de protocoles de drug design et criblage virtuel“. Paris 5, 2007. http://www.theses.fr/2007PA05P612.
Der volle Inhalt der QuelleThis thesis in structural bioinformatics and chemoinformatics concentrates on the optimization of the therapeutics compounds identification process. It relies on the three main components of the chemical compounds virtual screening: preparation of a computational version of the chemical library to be screened; identification of novel active compounds using chemical similarity with respect to known active molecules (LBVS); and identification of novel active compounds using the 3D structure of the target binding site (SBVS). This work implied: to develop a computer program (MED-3DMC) that generates conformation ensembles of small molecules ; then to create a LBVS program (MED-SuMoLig) that can screen thousands of chemical compounds using their pharmaco-topological profile; and finally to use a hierarchical SBVS procedure to identify novel inhibitors for protein-membrane interaction using the coagulation factor Va as a proof of concept
Florian, Maria Carmen. „Design, synthèse et analyse structurale de nouvelles molécules hôtes : Macrocycles et cyclophanes“. Rouen, 2006. http://www.theses.fr/2006ROUES034.
Der volle Inhalt der QuelleIn the first part, we reported the synthesis of new dispiro-1. 3-dioxane compounds as syn and anti isomers. The synthesis of new macromolecules embedding semiflexible dispiro-1. 3-dioxane units was performed by high-dilution technique and using the template effect. The design of these macrocyclic compounds is based on the stereochemistry of the precursors which show a favourable pre-organization for the incorporation in macrocycle systems. In the second part, we reported the synthesis and the stereochemistry of new 1. 3. 5-triacetylbenzene derivatives and the attempts to obtain new “cage” molecules from these derivatives
Taboureau, Olivier. „Bioinformatique et drug design : contribution à l'exploitation de grandes bases de données chimiques“. Orléans, 2001. http://www.theses.fr/2001ORLE2061.
Der volle Inhalt der QuelleRayar, Anita-Marie. „In silico drug design et chimie médicinale : développement de nouvelles molécules coumariniques, sélectives de la cyclooxygénase-2“. Thesis, Paris, CNAM, 2017. http://www.theses.fr/2017CNAM1085/document.
Der volle Inhalt der QuelleInflammation is a phenomenon affecting millions of people throughout the world. There is a broad range of inflammatory mediators implied in different biological functions including the cyclooxygenase-2. Although many selective inhibitors selective of COX-2 have been developed and marketed, they have displayed diverse side effects leading, in some cases, to their with drawal from the market. Nowadays, in silico methods are more and more used in the drug discovery process. In this project, we have used pharmacophoric models and docking methods to guide and prioritize the synthesis of molecules, presenting different and original structures, with enhanced affinity for the biological target. Thus, predictions realized with the TOMOCOMD-CARDD software together with biological tests enable to identify the cyclocoumarol as a potential anti-inflammatory molecule. As part of these works, the synthesis of and the study of cyclocoumarol analogues as selective inhibitors of COX-2 have been realized. Pharmacomodulation of cyclocoumarol and development of synthesis strategies led to a serie of cyclocoumarol analogues. Several bioinformatics tools have been used: selective COX-2 pharmacophores were elucidated using LigandScout and docking studies (Surflex) were conducted to understand the binding mode of different compounds. Finally, SeeSAR enabled to predict the affinity of the molecules the most susceptible to inhibit selectively COX-2. Biological tests confirmed their inhibitory activity against COX-2 and showed no significant inhibition for COX-1. Among the synthesized molecules, the 4-OMe cyclocoumarol has demonstrated an activity and a selectivity very interesting, similar to NS-398, a known selective COX-2 inhibitor.Based on the biological results obtained, a pharmacomodulation study of cyclocoumarol derivatives has been realized using in silico tools in order to predict the affinity of new compounds and to discover new selective inhibitors of COX-2.Keywords : cyclocoumarol, benzalacetones, warfarines, pharmacophores, docking, virtual screening, COX-2, repositioning
Mouhsine, Hadley. „Développement de nouveaux inhibiteurs du TNFα identifiés par Drug Design“. Thesis, Paris, CNAM, 2012. http://www.theses.fr/2012CNAM0842/document.
Der volle Inhalt der QuelleMonoclonal antibodies have been a revolution for the treatment of chronicinflammatory diseases but present several drawbacks (secondary effects, prohibitive costs,resistance)Our team develops TNFα inhibitors using two approaches : active immunizationagainst cytokine peptides and small compounds having a direct inhibition on TNFα.I have evaluated in vitro the best compounds selected after in silico screening of achemical library and I have identified a small molecule which was protective in two animalmodels (septic shock and DSS induced colitis). I have also analyzed chemical analogues ofthe best compounds found in vitro.I have also tested the immunogenicity of TNFα peptides but they did not yieldneutralizing antibodies in vitro, and we thus did not test them in vivo.My work was at the interface of bioinformatics, chemistry and biology, and this hasenabled me to understand the key issues in the modern development of drugs
Chakchouk, Mohamed. „Conceptiοn d'un détecteur de système mécatronique mobile intelligent pour observer des molécules en phase gazeuse en ΙR“. Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMIR06.
Der volle Inhalt der QuelleThis work anticipates that, in an ever-expanding digital technology world, technological breakthroughs in the analysis of data collected by spectroscopic devices will allow the almost instantaneous identification of known species observed in-situ in a specific environment, leaving the necessary in-depth analysis of unobserved species. The method derived from RBDO (Reliability Based Design Optimization) technology will be used to implement an artificial intelligence procedure to identify observed species from a mobile IR sensor. To successfully analyze the obtained data, it is necessary to appropriately assign molecular species from the observed IR data using appropriate theoretical models. This work focuses on the observation from mobile devices equipped with appropriate sensors, antennas, and electronics to capture and send raw or analyzed data from an interesting IR spectroscopic environment. It is therefore interesting if not essential to focus on symmetry-based theoretical tools for the spectroscopic analysis of molecules, which allows to identify the IR windows to be chosen for observation in the design of the device. Then, by fitting the theoretical spectroscopic parameters to the observed frequencies, the spectrum of a molecular species can be reconstructed. A deconvolution of the observed spectra is necessary before the analysis in terms of intensity, width and line center characterizing a line shape. Therefore, an adequate strategy is needed in the design to include data analysis during the observation phase, which can benefit from an artificial intelligence algorithm to account for differences in the IR spectral signature. In this regard, the analytical power of the instrument data can be improved by using the reliability-based design optimization (RBDO) methodology. Based on the multi-physics behavior of uncertainty propagation in the hierarchical system tree, RBDO uses probabilistic modeling to analyze the deviation from the desired output as feedback parameters to optimize the design in the first place. The goal of this thesis is to address IR observation window parameters to address reliability issues beyond mechatronic design to include species identification through analysis of collected data
Douguet, Dominique. „Etude des interactions protéine-protéine et protéine-ligand par bio- et chimie-informatique structurale : Identification de petites molécules bio-actives“. Habilitation à diriger des recherches, Université de Nice Sophia-Antipolis, 2007. http://tel.archives-ouvertes.fr/tel-00320089.
Der volle Inhalt der QuelleLa modélisation par homologie permet d'obtenir un modèle tridimensionnel d'une protéine lorsque sa structure n'a pas été déterminée expérimentalement. Ma contribution dans ce domaine fut la réalisation du serveur @TOME avec le soutien de la GENOPOLE Languedoc-Roussillon (accessible à l'adresse http://bioserver.cbs.cnrs.fr). Ce serveur était le premier de ce type à avoir été développé en France. Le serveur @TOME rassemble et traite d'une manière automatique toutes les étapes nécessaires à la construction d'un modèle 3D d'une protéine. Cela inclut la reconnaissance du repliement, la construction des modèles protéiques et leur évaluation. Les résultats du CASP5 en 2005 (session internationale d'évaluation des méthodes de prédiction de la structure des protéines ; http://predictioncenter.llnl.gov/) ont montré que notre serveur utilisé en mode automatique propose des modèles très proches de la structure expérimentale lorsque l'identité de séquence avec la structure support est supérieure à 30%. Le serveur a été classé 26ième sur 187 groupes inscrits.
Dans un second temps, mes recherches m'ont permis de réaliser une base de données de complexes protéiques co-cristallisés, base fondatrice du projet DOCKGROUND. Ce projet de grande envergure, soutenu par le NIH depuis 2005, vise à établir un système intégré et dynamique de bases de données dédié à l'étude et à la prédiction des interactions entre protéines et permettre ainsi d'améliorer nos connaissances des interactions et de développer des outils de prédiction plus fiables. Ce travail a été effectué au sein de l'équipe du Pr. Ilya Vakser à l'Université de Stony Brook, NY, USA. Dans la réalisation de cette première base de données, un ensemble de programmes collectent, classent et annotent les complexes protéiques qui ont été co-cristallisés (données sur la séquence, la fonction, le repliement 3D, les particularités telles qu'une fixation à de l'ADN, ...). Ensuite, j'ai mis en œuvre une sélection dynamique des représentants des complexes contenus dans cette base. Les représentants sont essentiels pour éviter une surreprésentation de certaines familles de protéines. Cette base de donnée est accessible par Internet et est régulièrement mise à jour (http://dockground.bioinformatics.ku.edu). Le projet DOCKGROUND va être poursuivi par la réalisation de 3 autres bases de données qui s'ancreront sur la présente appelée ‘Bound-Bound'.
L'objectif principal de mes travaux est d'identifier de nouveaux composés bio-actifs afin de comprendre le fonctionnement de leur cible dans un contexte biologique. Les méthodes que j'utilise se basent sur la chémoinformatique, le criblage virtuel et le de novo ‘drug design'. Dans le cadre de ce dernier, j'ai mis au point un programme propriétaire LEA3D (‘Ligand by Evolutionary Algorithm' 3D). Le programme génère des petites molécules à partir de la combinaison de fragments moléculaires issus de drogues et de molécules ‘bio' (substrats ou produits de réactions enzymatiques). Le criblage virtuel basé sur la structure protéique et le de novo ‘drug design' par LEA3D, ont été appliqués avec succès à la thymidine monophosphate kinase (TMPK) de Mycobacterium tuberculosis dans le cadre d'une collaboration avec une équipe de chimistes et de biologistes de l'Institut Pasteur. De nouvelles familles d'inhibiteurs ont été identifiées dont un inhibiteur synthétique trois fois plus affin que le substrat naturel. Plusieurs publications et une demande de brevet couvrent les résultats de ces recherches. Dans la continuité de ces travaux, je m'intéresse maintenant, plus particulièrement, à développer des stratégies de criblages de fragments (molécules de petit poids moléculaire). Il a été montré que de petites chimiothèques contenant des petites molécules polaires sont plus efficaces pour identifier des touches. Ce travail doit être réalisé conjointement avec des criblages structuraux expérimentaux comme la RMN ou la diffraction des rayons X. Ces derniers se posent comme une alternative aux tests in vitro avec pour avantage de donner une information détaillée, au niveau atomique, des interactions entre le ligand et sa cible. S'ensuit une étape d'optimisation/maturation des touches en ligands plus élaborés et plus affins par l'utilisation d'outils de chémoinformatique.
Panei, Francesco Paolo. „Advanced computational techniques to aid the rational design of small molecules targeting RNA“. Electronic Thesis or Diss., Sorbonne université, 2024. http://www.theses.fr/2024SORUS106.
Der volle Inhalt der QuelleRNA molecules have recently gained huge relevance as therapeutic targets. The direct targeting of RNA with small molecule drugs emerges for its wide applicability to different classes of RNAs. Despite this potential, the field is still in its infancy and the number of available RNA-targeted drugs remains limited. A major challenge is constituted by the highly flexible and elusive nature of the RNA targets. Nonetheless, RNA flexibility also presents unique opportunities that could be leveraged to enhance the efficacy and selectivity of newly designed therapeutic agents. To this end, computer-aided drug design techniques emerge as a natural and comprehensive approach. However, existing tools do not fully account for the flexibility of the RNA. The project of this PhD work aims to build a computational framework toward the rational design of compounds targeting RNA. The first essential step for any structure-based approach is the analysis of the available structural knowledge. However, a comprehensive, curated, and regularly updated repository for the scientific community was lacking. To fill this gap, I curated the creation of HARIBOSS ("Harnessing RIBOnucleic acid - Small molecule Structures"), a database of all the experimentally-determined structures of RNA-small molecule complexes retrieved from the PDB database. HARIBOSS is available via a dedicated web interface (https://hariboss.pasteur.cloud), and is regularly updated with all the structures resolved by X-ray, NMR, and cryo-EM, in which ligands with drug-like properties interact with RNA molecules. Each HARIBOSS entry is annotated with physico-chemical properties of ligands and RNA pockets. HARIBOSS repository, constantly updated, will facilitate the exploration of drug-like compounds known to bind RNA, the analysis of ligands and pockets properties and, ultimately, the development of in silico strategies to identify RNA-targeting small molecules. In coincidence of its release, it was possible to highlight that the majority of RNA binding pockets are unsuitable for interactions with drug-like molecules, attributed to the lower hydrophobicity and increased solvent exposure compared to protein binding sites. However, this emerges from a static depiction of RNA, which may not fully capture their interaction mechanisms with small molecules. In a broader perspective, it was necessary to introduce more advanced computational techniques for an effective accounting of RNA flexibility in the characterization of potential binding sites. In this direction, I implemented SHAMAN, a computational technique to identify potential small-molecule binding sites in RNA structural ensembles. SHAMAN enables the exploration of the target RNA conformational landscape through atomistic molecular dynamics. Simultaneously, it efficiently identifies RNA pockets using small probe compounds whose exploration of the RNA surface is accelerated by enhanced-sampling techniques. In a benchmark encompassing diverse large, structured riboswitches as well as small, flexible viral RNAs, SHAMAN accurately located experimentally resolved pockets, ranking them as preferred probe hotspots. Notably, SHAMAN accuracy was superior to other tools working on static RNA structures in the realistic drug discovery scenario where only apo structures of the target are available. This establishes SHAMAN as a robust platform for future drug design endeavors targeting RNA with small molecules, especially considering its potential applicability in virtual screening campaigns. Overall, my research contributed to enhance our understanding and utilization of RNA as a target for small molecule drugs, paving the way for more effective drug design strategies in this evolving field
Wang, Shenming. „Design and synthesis of organic luminescent materials with a 2,2′-bipyrimidine scaffold for hybrid LED lighting“. Electronic Thesis or Diss., Institut polytechnique de Paris, 2024. http://www.theses.fr/2024IPPAX016.
Der volle Inhalt der QuelleOrganic luminescent materials possess a lot advantages over the inorganic analogues. By carefully designing, they can exhibit efficiency fluorescence in visible area with tunable emission color and strong absorption in near-UV and blue region. Due to this, they can be made in thin films for light-weight optoelectronic devices. They can be highly soluble in organic solvent which provide the possibility for the solution-processing techniques, such as spin-coating and slot-die coating. They are metal-free, which is desired for the sustainable development. In this case, the organic luminescent compound could be a promising alternative to the inorganic phosphor utilized in commercial white LEDs for the improvements of the light quality.In this work, we are aiming at designing and synthesizing greatly efficient organic luminescent materials for down-converting the near-UV or blue light from the light-emitting diodes (LEDs) based on inorganic semiconductors into visible light, ideally white light. Therefore, the target application is called hybrid LEDs. The frequently employed molecular design strategies include: (1) the donor-acceptor (D-A) approach, which can adjust the bandgap in order to tune the absorption wavelength and emission color; (2) aggregation-induced emission (AIE) is introduced for avoiding the significant quenching of the emission in solid state which is owing to the aggregates.Herein, we designed and synthesized a series of D-A molecules M1-M7 implementing new acceptors, 2,2′-bipyrimidine derivatives, as building block. They were purified and taken to the photophysical investigations in both diluted solutions and solid state. They showed tunable emission color, strong fluorescence and absorption, more importantly, high conversion rate from near -UV external source to visible light. We also inspected their photostabilities to estimate their lifespans. In the end, the blenders of different emitters are made for generating white light
Bücher zum Thema "Design de Molécules"
Rai, Beena. Molecular Modeling for the Design of Novel Performance Chemicals and Materials. Taylor & Francis Group, 2012.
Den vollen Inhalt der Quelle findenRai, Beena. Molecular Modeling for the Design of Novel Performance Chemicals and Materials. Taylor & Francis Group, 2019.
Den vollen Inhalt der Quelle findenRai, Beena. Molecular Modeling for the Design of Novel Performance Chemicals and Materials. Taylor & Francis Group, 2012.
Den vollen Inhalt der Quelle findenMolecular modeling for the design of novel performance chemicals and materials. Boca Raton: CRC Press, 2012.
Den vollen Inhalt der Quelle findenKonferenzberichte zum Thema "Design de Molécules"
Jendreiko, Christian, und Tomas Veloz. „Modelo de Química Artificial como linguagem de criação artística“. In LINK 2021. Tuwhera Open Access, 2021. http://dx.doi.org/10.24135/link2021.v2i1.160.g239.
Der volle Inhalt der Quelle